Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease
about
The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia.IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells.Sorbicillinoid analogs with cytotoxic and selective anti-Aspergillus activities from Scytalidium albumImmunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia.Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemiaBRAFV600E induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation.Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia.The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cellsCell lines generated from a chronic lymphocytic leukemia mouse model exhibit constitutive Btk and Akt signaling.Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.
P2860
Q33688473-3CB880F3-972C-43CD-BFC0-2B157770B988Q34636880-61DDC1D7-347D-4D15-BE9E-CC73FA0B00FCQ35214188-F00321CA-F2E1-48F5-8BCD-4E90E9C9C59BQ35377918-24BF223D-8A12-4CDC-8ED4-4A61E6A4642EQ36000944-85B81516-18DA-446A-8FF8-40855C00787EQ36651344-49B58E43-9069-45F9-817A-4FFBFB21B33DQ36654999-C8D6B2BD-1998-4338-933E-5CED038C808AQ37317644-E6A29B3E-17D0-46E8-A567-F5B3C904ADA0Q37747342-5FA73454-7CA6-4918-8281-A9CE4EE34027Q39877099-E30EF144-819D-4C33-BB5C-3EDECDED4CC7Q42700845-04C6998C-E519-4799-BC55-DA3E805EF77BQ49789839-06383E28-69E6-4FEE-9C95-E376CC900955Q52562958-0AF38638-3775-42EA-A431-5987268C9A96
P2860
Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Characterization of a new chro ...... vo studies relevant to disease
@ast
Characterization of a new chro ...... vo studies relevant to disease
@en
Characterization of a new chro ...... vo studies relevant to disease
@nl
type
label
Characterization of a new chro ...... vo studies relevant to disease
@ast
Characterization of a new chro ...... vo studies relevant to disease
@en
Characterization of a new chro ...... vo studies relevant to disease
@nl
prefLabel
Characterization of a new chro ...... vo studies relevant to disease
@ast
Characterization of a new chro ...... vo studies relevant to disease
@en
Characterization of a new chro ...... vo studies relevant to disease
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Characterization of a new chro ...... vo studies relevant to disease
@en
P2093
Amy J Johnson
Amy Lehman
Amy S Ruppert
Arletta Lozanski
Brad Bolon
David E Symer
Erin Hertlein
Gerard Lozanski
Kyle A Beckwith
Laura Rassenti
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0076607
P407
P577
2013-01-01T00:00:00Z